Ziyue Xu

1PUBLICATIONS
1CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Sep 26, 2025
Clinicopathological and molecular correlates of clinical benefit from disitamab vedotin (RC48), a HER-2-targeting antibody-drug conjugate, in metastatic urothelial carcinoma: a multi-center, real-world study.

Zhaopei Liu, Kaifeng Jin, Ziyue Xu

Pageof 1

Frequent Collaborators

1 joint publications

Zhaopei Liu